<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>ETHNOPHARMACOLOGICAL RELEVANCE: Total <z:chebi fb="1" ids="26605">saponins</z:chebi> of Panax notoginseng (TSPN), main constituents extracted from Panax Notoginseng, a highly valued traditional Chinese medicine, have been shown to be an effective agent on <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>AIM OF THE STUDY: The effects of TSPN on <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and expressions of caspase-1, caspase-3 and caspase-8 were studied after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> for 2 h followed by reperfusion for 46 h in rats </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: Rats were subjected to transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model using the intraluminal thread </plain></SENT>
<SENT sid="3" pm="."><plain>TSPN was administered intraperitoneally at 5 min before and 12 h, 24 h and 36 h after MCAO, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: TSPN (at the dose of 25 mg/kg) significantly attenuated TUNEL-positive cells and reduced the expression of caspase-1 and caspase-3 compared to the model group, while it had no obvious effect on the expression of caspase-8 </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: The neuroprotective effect of TSPN on focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> may be related to inhibition of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and caspases activation </plain></SENT>
</text></document>